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Background:  Hemolysis continues to be a challenge in patients supported by left ventricular assist devices (LVADs) and can occasionally 
lead to LVAD thrombosis and the necessity for surgical exchange. We investigated possible risk factors for hemolysis.
methods:  This retrospective study included 227 patients implanted with HeartMate II LVADs. Patients were stratified based on history 
of hemolysis (defined as hospital admission for suspected thrombus and LDH > 650u/L). Baseline demographic, hemodynamic, and 
laboratory information was obtained. Post LVAD incidence of major adverse effects was tabulated. Data was compared using student’s 
t-test and chi-square analyses.
results:  We identified 17 cases of patients hospitalized with hemolysis. Patients in the hemolysis group were significantly younger in 
age, had higher BMI, were more likely African American, and had higher incidences of diabetes and obstructive sleep apnea (Table 1). The 
hemolysis group was found to be associated with higher LVAD speeds at discharge. These patients also had higher incidence of pump 
exchange. There were no differences between the two groups in survival or incidence of stroke, heart failure, GI bleeding, or infections.
conclusion:  Our results indicate potential patient factors that may be associated with increased risk of hemolysis and suggest that 
incidence of hemolysis while on mechanical circulatory support may be reduced with the use of lower device speeds.
Differences Between Patients with Hemolysis and No Hemolysis
Hemolysis Positive N=17 Hemolysis Negative N=227 p-value
Age (years) 52.18 (±14) 61.05 (±12) 0.04
BMI (kg/m) 31.2 (±6.6) 27.50 (±6.1) 0.02
INTERMACS > 3 12 (71%) 98 (47%) 0.06
African American Race 11 (65%) 74 (35%) 0.016
History of Diabetes 12(71%) 90 (43%) 0.027
History of Obstructive Sleep Apnea 7 (41%) 38 (18%) 0.02
LVAD Speed at Discharge (RPM) 9424 (±307) 9214 (±337) 0.014
Survival 14 (±82%) 135 (±64%) 0.13
Pump Exchange 8 (±47%) 31 (±15%) 0.001
